XTL Biopharmaceuticals Market Cap

XTL Biopharmaceuticals has a market cap or net worth of 48.48 million as of February 21, 2025. Its market cap has increased by 154.18% in one year.

Market Cap

48.48M

Enterprise Value

42.08M

Revenue

171.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

5.50

Market Cap Chart

Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 48.48M, a decrease of -93.98%. That is a compound annual growth rate of -13.43%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2025	48.48M	-15.38%
Dec 31, 2024	57.29M	200.39%
Dec 31, 2023	19.07M	-14.63%
Dec 29, 2022	22.34M	-52.02%
Dec 30, 2021	46.56M	-7.60%
Dec 31, 2020	50.39M	108.51%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	69.73B
Danel (Adir Yeoshua)	2.53B
Kamada	1.59B
Bait Bakfar	1.07B
Novolog (Pharm-Up 1966)	896.31M
Ilex Medical	814.57M
BrainsWay	780.49M
SofWave Medical	607.05M

Market Cap Rankings